Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.
暂无分享,去创建一个
Benjamin Movsas | Walter J Curran | Elizabeth Gore | Mitchell Machtay | William Sause | W. Curran | R. Komaki | S. Hauser | W. Sause | B. Movsas | J. Cox | S. Rosenthal | C. Langer | R. Paulus | E. Gore | T. Wasserman | M. Machtay | Seth A Rosenthal | Rebecca Paulus | Corey J Langer | Ritsuko Komaki | Jin S Lee | Stephen Hauser | Todd Wasserman | James D Cox | Jin Lee | J. Cox
[1] C. Perez,et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non‐oat cell carcinoma of the lung. Report by the radiation therapy oncology group , 1982, Cancer.
[2] K. Oysul,et al. Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer. , 2000, Radiation medicine.
[3] D. Ettinger,et al. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90‐15 , 1995, Cancer.
[4] R W Makuch,et al. Sample size requirements for comparing time-to-failure among k treatment groups. , 1982, Journal of chronic diseases.
[5] Walter J Curran,et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M Zelen,et al. The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.
[7] Jeffrey Bradley,et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.
[8] B. Jeremic,et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] K. Propert,et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.
[11] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[12] W. Curran,et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[14] R. Simon,et al. Two multi-step selection procedures with Possible selection of two treatments of equal prior preference , 1994 .
[15] J. Herndon,et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[17] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] G. Giaccone,et al. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). , 2007, European journal of cancer.
[19] Ladislav Pecen,et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. , 2004, Lung cancer.
[20] W. Curran,et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. , 1995, Journal of the National Cancer Institute.